MDR 5.13% 41.0¢ medadvisor limited

share price disappointing, page-4

  1. 4,198 Posts.
    lightbulb Created with Sketch. 228
    Tend to agree Varuka.

    The carrot has been international revenue and we (the donkeys) have invested based on this to grow the AU financials. I’ve stated a few times the international deals through PDX, Adheris, Zuellig, MedExpress, Klinify, Alpro, HMS, Day Lewis etc have been announced over the last 6-24 months but revenue has not been converted or received from any of them.

    Either we’ve been deceived or there might be a big bang in FY21. Based on the new appointees I believe it will be the latter, but the delays, to put it politely, has been disappointing.
    Last edited by futurenow: 22/07/20
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.